An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.
Some experts said the demand for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic content and banned associated keywords and query recommendations. The organization said it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within minutes of joining one group, a seller posted contact information, where most transactions occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, health issues or previous experience.
Item Information and Pricing
Within these groups, messages show dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service stated it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially significant medical dangers”.
